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J wave syndrome has emerged as a significant cause of Idiopathic ventricular fibrillation
(IVF) responsible for sudden cardiac death. A large body of data is now available on genesis,
genetics and ionic mechanisms of J wave syndromes. Two of these viz., Early repolarization
syndrome (ER) and Brugada syndrome (BrS) are fairly well characterized enabling correct
diagnosis in most patients. The first part of repolarization of ventricular myocardium is
governed by Ito current i.e., rapid outward potassium current. The proposed mechanism of
ventricular fibrillation (VF) and ventricular tachycardia (VT) storms is the faster Ito current
in the epicardium than in the endocardium results in electrical gradient that forms the
substrate for phase 2 reentry. Prevention of Ito current with quinidine supports this
mechanism. Majority of ER patterns in young patients are benign. The key issue is to
identify those at increased risk of sudden cardiac death. Association of both ER syndrome
and Brugada syndrome with other disease states like coronary artery disease has also been
reported. Individuals resuscitated from VF definitely need an implantable cardiac defi-
brillator (ICD) but in others there is no consensus regarding therapy. Role of electrophys-
iology study to provoke ventricular tachycardia or fibrillation is not yet well defined.
Radiofrequency ablation of epicardial substrate in right ventricle in Brugada syndrome is
also under critical evaluation. In this review we shall discuss historical features, epide-
miology, electrocardiographic features, ionic pathogenesis, clinical features and current
status of proposed treatment of ER and BrS.
Copyright © 2014, Cardiological Society of India. All rights reserved.1. Introduction
Syndromeword comes from Latin/Greek andmeans syndrome,
literally: a running together, (from SYN- þ dramein to run). In
medicine it is defined as any combination of signs and
symptoms that are indicative of a particular disease or(K.K. Sethi).
ociety of India. All rightsdisorder with multiple etiologies. J wave syndrome is a
recently recognized entity that is being defined, and perhaps
encompasses more than one condition. The letter ‘J’ means
junction and actually here it defines the junction point of QRS
with ST segment.1 Electrical activity recorded by electrocar-
diogram (ECG) is a recording of action potentials (AP) resulting
frommovement of ions acrossmyocardial membrane causingreserved.
i n d i a n h e a r t j o u r n a l 6 6 ( 2 0 1 4 ) 4 4 3e4 5 2444depolarization (contraction of myocardial sarcomere), fol-
lowed by return of ions to basal state causing repolarization
(relaxation). This action potential has five components labeled
as phases 0e4, 0 being depolarization and 1e4 repolarizations.
Junction point of end of depolarization and onset of repolari-
zation is the J-point on ECG and on the action potential curve.
Ionmovement is through pores/channels made up of proteins
that are regulated by genes. Disorders caused by altered
channels/ion movements known as channelopathies are
possibly monogenetic syndromes.2,3
Two important J wave syndromes have been described viz.,
Early repolarization syndrome (ER) and Brugada syndrome
(BS). We shall discuss about pathophysiology, clinical symp-
tom constellation, diagnostic methods and treatment of these
conditions.12. Genesis of abnormal action potential
Inward movement of Na across the cell membrane through a
specific channel produces inward current and causes depo-
larization. Outward movement of K causes repolarization.
There are 8 types of Potassium (K) currents. The plateau phase
of action potential AP depends on balance between inward
(depolarizing) and outward (repolarizing) currents. Ventricu-
lar myocardium has actually three layers of muscles viz.,
epicardial, M cells and endocardial layer. To some extent the
M cells resemble Purkinje cells. In normal state there is ho-
mogenous genesis of action potential across the three layers
(Fig. 1). Abnormality of any layer would lead to aberration in
action potential and development of ionic gradient between
the layers with consequent development of slow conduction,
forming a substrate for reentry in phase 2. The first phase of
repolarizationwith a dome like small hump is due to K current
called Ito (transient outward current) (Fig. 2). Uneven distri-
bution with resultant gradient of Ito between epicardium and
endocardium results in J-point elevation. Hypothermia and
hypocalcaemia enhance J wave development.23. Early repolarization syndrome
ER is characterized by prominent J-point on ECG with notch-
ing/slurring of distal part of R wave which more or less ap-
pears as pseudo delta wave. J notches are known for long timeFig. 1 e Possible mechanism of J wave genesis. Actand are actually present in 2e10% of general population. J
wave attracted significant clinical attention following publi-
cation of Haissaguerre et al,4 where they showed relationship
of Idiopathic Ventricular Fibrillation with ER. In this case
controlled study, young patients who were successfully
resuscitated from idiopathic ventricular fibrillation were
carefully reviewed, their baseline ECG revealed prominent J
waves in inferolateral leads which could not be explained by
the trauma of sudden cardiac arrest, resuscitation efforts or
drugs used for resuscitation. Considerable interest was
generated following this landmark paper, and benign versus
malignant varieties of ER were described. The former is an
asymptomatic ECG finding in general population, while the
latter presents with history of ventricular fibrillation.4. History of J wave recognition
The pattern of ER and J deflection presenting as slurring or
notching of the terminal part of QRS complex was first
described in 1936 by Shipley and Hallaran and was considered
a normal ECG variant.5 In 1938, Tomaszewski presented the
case of an accidentally frozenmanwhose ECG depicted a very
slowly inscribed deflection between the QRS complex and the
ST segment, representing a J wave.6 In 1953, Osborn described
a “current of injury” later named “the Osbornwave” in acidotic
and hypothermic dogs at rectal temperatures less than 25 C.7
In 1961,Wasserburger et al further defined early repolari-
zation as a 1e4 mm takeoff of the ST segment from the iso-
electric line accompanied by downward concavity of the ST
segment and symmetrically limbed T wave often of large
amplitude in the mid to left precordial leads.8
In 1984, Otto et al described three cases of Ventricular
fibrillation (VF) with structurally normal hearts that showed
ER to be nomore benign. They presented three cases of VF that
occurred during sleep in youngmale Southeast Asian refugees
who had structurally normal heart and the only prominent
ECG abnormality in these patients was a prominent J wave
accompanied by ST segment elevation.9
In 1999, Gussak and Antzelevitch suggested that early
repolarization may be malignant in some cases, based on
observations that an early repolarization pattern in arterial
perfused wedge preparations can easily convert to one in
which phase 2 reentry gives rise to polymorphic ventricular
tachycardia (VT)/VF.10ion potential in normal and J wave syndrome.
Fig. 2 e Ito responsible for ER.
i n d i a n h e a r t j o u rn a l 6 6 ( 2 0 1 4 ) 4 4 3e4 5 2 445In 2000, evidence supporting above hypothesis was pro-
vided by Kalla et al and Takagi et al; they reported VF in pa-
tients with prominent J wave and ST segment elevation in
inferior leads without structural heart diseases and postu-
lated that idiopathic VF with an early repolarization pattern in
inferior leads may represent a variant of the Brugada
syndrome.11,12
In 2008, Haissaguerre et al4 andNamet al13 demonstrated a
definitive association between J waves and the pathogenesis
of many different forms of idiopathic VF.5. Types of early repolarization (ER)
Antzelevitch et al described early repolarization syndrome
into three subtypes15:
Type 1: Early repolarization pattern predominantly in the
lateral precordial leads. This form is very prevalent among
healthy male athletes and is rarely seen in VF survivors.
Type 2: Early repolarization pattern predominantly in the
inferior sor inferolateral leads. Numerous cases of otherwise
idiopathic VF have this ECG pattern, this is also prevalent in
healthy young males.
Type 3: Early repolarization pattern globally in the inferior,
lateral, and right precordial leads and is associated with the
highest level of risk for development ofmalignant arrhythmia.
It is often associated with VT/VF storms.
Tikkanen et al.15 proposed another classification (Fig 3). ER
is J-point and ST segment elevation >1 mm in 2 or more
contiguous leads. Two types of J-point elevation are described:
1. J-point with rapidly ascending ST segment, considered a
Benign form.
2. J-point with horizontal or descending ST segment,
considered a Malignant form.
ER in inferolateral lead is more associated with ventricular
fibrillation.16 ER ECG pattern (>1 mm) in the inferior/lateralleads occurs in 1e13% of the general population and in
15e70% of Idiopathic VF cases. In the pediatric age group it is
even more prevalent. Male sex is strongly associated with ER
ECG pattern, since over 70% of subjects with ER are males, its
prevalence declines in males from early adulthood until
middle-age which suggests a hormonal influence on the
presence of ER. The ER pattern is more common in young
physically active individuals, athletes, and African-
Americans. There is an increased prevalence of ER reported
in Southeast Asians. The ER pattern is associated with high
vagal tone, as well as hypothermia and hypocalcaemia.176. Clinical diagnosis
Following clinical patterns are now known14,15:
1. Asymptomatic and incidentally detected ER is very com-
mon in young athletes. The prevalence and magnitude of
ER increase as their training intensifies.
2. Malignant variety with Idiopathic VF and Sudden cardiac
death (SCD).
3. ER with Coronary artery disease (CAD) with increased risk
of having ischemic VF. ER pattern recorded during
ischemic event is strongest predictor of VF occurrence.
4. ER has been linked to high cardiac death and arrhythmic
death rates in vasospastic angina.
5. Idiopathic VF is reported with horizontal or down-sloping
ST following J-point elevation (Fig. 3).
7. Genetic basis and variants
The genetic basis for early repolarization is not well defined.
Genetic contributions to ER are suggested by anecdotal ob-
servations of a common familial history of SCD in subjects
with ER and idiopathic VF. Familial ER has been reported to
have an autosomal dominant inheritance pattern with
incomplete penetrance. Two independent population-based
studies also have suggested some degree of inheritance of
the ER patterns in the general population, but the familial
inheritance of malignant ER patterns has not been clearly
demonstrated. A candidate gene approach in idiopathic VF
patients with ER has identified a mutation in KCNJ8, which
encodes a pore-forming subunit of the ATP-sensitive potas-
sium channel.
Mutations in the L-type calcium channel genes, including
CACNA1C, CACNB2B, and CACNA2D1 as well as loss-of-
function mutations in SCN5A have also been associated with
idiopathic VF with ER. Given the high prevalence of ER in the
general population, ER likely has a polygenic basis that also is
influenced by non-genetic factors.18e208. Diagnosis
There are no validated techniques to provoke the ER pattern,
although 12-lead Holter monitoring to detect evidence of the
ER pattern during bradycardia is warranted. In survivors of VF
Fig. 3 e A. Benign type with rapidly ascending ST and B. Malignant type with horizontal variety of ER.
i n d i a n h e a r t j o u r n a l 6 6 ( 2 0 1 4 ) 4 4 3e4 5 2446and in patients with polymorphic VT, clinical evaluation to
rule out structural heart disease including echo-cardiogram,
coronary angiography, magnetic resonance imaging (MRI),
and in selected cases, endomyocardial biopsies should be
performed to exclude other causes of VF.9. Risk stratification
The magnitude of the J-point elevation may have prognostic
significance (Figs. 4 and 5). Either slurred or notched J-point
elevation 0.2 mV is relatively rare in the general population,
but appears to be associated with an increased risk. Further-
more, J-point elevation in idiopathic VF patients is of greater
amplitude and ECG lead distribution compared to those with
an established cause of cardiac arrest. The available data also
suggest that transient changes in the presence and amplitude
of J-point elevation portend a higher risk for VF. A horizontal
or descending ST segment following J-point elevation is
associated with a worse outcome in the general population.
This observation has been very helpful in distinguishing
idiopathic VF.14e1610. Management
The clinical implications of the observation of an ER pattern
in the ECG of an asymptomatic subject are not clear at this
stage. The presence of ER is associated with 3 times the risk
of developing VF, but the overall risk is still negligible
considering the rarity of VF in the general population.
Because the presence of ER may increase the vulnerability to
sudden death during an acute ischemic event, a plausible
implication coming from the population studies is that
middle-aged subjects with the ER pattern in the ECG, espe-
cially those with a high amplitude of J-point elevation and
horizontal (2 mm) or down-sloping ST segment, should
target a reduction in their long-term risk for acute coronary
events in accordance with current practice guidelines. Elec-
trical storm is relatively common after ICD implantation in
patients with the ER syndrome. Case series evidence sup-
ports the acute use of isoproterenol for suppression of
recurrent VF, and quinidine for long-term suppression.
Isoproterenol is typically initiated at 1.0 mg/min, targeting a
20% increase in heart rate or an absolute heart rate >90 bpm,
Fig. 4 e ER with J-point elevation in Inferior and lateral leads.
Fig. 5 e Inferolateral early repolarization patterns and
magnitude of risk of sudden cardiac death. Estimated
prevalence in the general population is manifested by
width of the pyramid. Highest risk is on the top of the
pyramid, and lowest on the bottom (Adapted from Junttila
MJ et al15).
i n d i a n h e a r t j o u rn a l 6 6 ( 2 0 1 4 ) 4 4 3e4 5 2 447titrated to hemodynamic response and suppression of
recurrent ventricular arrhythmia.21,2211. Screening of family members
No recommendations can be given to do ECG screening of the
families of individuals with asymptomatic ER pattern or in-
dividuals with strong family history of ER or ER with VF. There
are no established provocative tests to diagnose concealed ER
in family members of ER syndrome patients, although pre-
liminary observation suggest that the Valsalvamaneuver may
assist in identifying concealed ER cases.21,2211.1. Treatment
Following are recommendations from latest Consensus
document of HRS/ACC/ESC.2211.2. Class I
1. ICD implantation is recommended in patients with a
diagnosis of ER syndrome who have survived a cardiac
arrest.11.3. Class II a
1. Isoproterenol infusion can be useful in suppressing elec-
trical/VT storms in patientswith diagnosis of ER syndrome.
2. Quinidine in addition to an ICD can be useful for secondary
prevention and suppression of VT/VF in patients with a
diagnosis of ER syndrome.
i n d i a n h e a r t j o u r n a l 6 6 ( 2 0 1 4 ) 4 4 3e4 5 244811.4. Class II b
1. ICD implantation may be considered in symptomatic
family members of ER syndrome, with history of syncope
in the presence of ST segment elevation >1 mm in 2 or
more inferior or lateral leads.
2. ICD implantation may be considered in asymptomatic in-
dividuals who demonstrate a high-risk ER ECG pattern
(high J-wave amplitude, horizontal/descending ST) in
infero-posterior leads the presence of a strong family his-
tory of juvenile unexplained sudden death with or without
a pathogenic mutation.
11.5. Class III
ICD implantation is not recommended in asymptomatic pa-
tients with an isolated ER pattern on ECG.11.6. Conclusion
Clearly now ER pattern and ER syndrome are distinct entities,
former being more common in young healthy individuals and
athletes. Resuscitated VF with ER on ECG and symptomatic ER
patients need to be treated with ICD. ER patterns with risk of
degenerating into VF are being recognized; horizontal ST after
notchbeingone,but there isnoconsensusyet. EPstudyforVT/VF
induction is not useful and no provocative tests for induction of
classical ER are available yet. Recommendations for sports
participation and screening of family members are not yet
defined but hopefully ongoing research shall show us light in
near future.2312. Brugada syndrome (BrS)
12.1. History
In 1992, Pedro and Josep Brugada published a landmark study
describing eight sudden cardiac death patients in whom the
ECG revealed “right bundle branch block” and ST segment
elevation in precordial leads V1 to V3, without obvious
structural heart diseases named this entity “Brugada syn-
drome.”24 In many cases of Brugada syndrome, the “right
bundle branch block” appears without an S wave in the left
precordial leads, suggesting that, in these cases, the right
bundle branch block is apparent and that R represents an
accentuation of the J wave. Second consensus conference
report, published in 2005, focused on diagnosis, risk stratifi-
cation schemes and approaches to therapy.2512.2. Epidemiology
Limited data is available on the epidemiology of BrS. It is prev-
alent in Asian and Southeast Asian countries, especially
Thailand, Philippines and Japan, reaching 0.5e1 per 1000. In
some parts of Asia, BrS seems to be themost common cause of
natural death inmen younger than 50 years. BrS is known as Lai
Tai (Thailand), Bangungut (Philippines), andPokkuri (Japan). The
reason for this higher prevalence in Asia is unknown. However,it has been speculated that itmay be in part related to an Asian-
specific sequence in the promoter region ofSCN5A.25e27
BrS is 8e10 timesmore prevalent in males than in females.
The presence of a more prominent transient outward current
(Ito) in males may be contributive. Higher testosterone levels
also may have a significant role in the male predominance.25
12.3. Genetics of Brugada syndrome
BrS has an autosomal dominant mode of transmission with
variable penetrance. Twelve responsible genes have been re-
ported so far. In all 12 genotypes, either a decrease in the in-
ward sodium or calcium current, or an increase in one of the
outward potassium currents has been shown to be associated
with the BrS phenotype. Genetic abnormalities are found in
one third of genotyped BrS patients.SCN5A, the gene that en-
codes for the a subunit of the cardiac sodium channel, account
for less than 30% of clinically diagnosed BrS patients.28
12.4. Clinical manifestations
BrS may be just an ECG detected accidental finding in an
asymptomatic individual. Symptoms associated with BrSmay
include: Ventricular fibrillation (VF) or aborted sudden cardiac
death (SCD), more often at night than during the day; pre-
syncope or syncope; Nocturnal agonal respiration; episodic
palpitation or atypical Chest pain.
These symptoms frequently occur during (i) febrile illness,
(ii) rest or sleep or (iii) with vagotonic conditions, but rarely (iv)
during exercise.
The syndrome typically manifests during adulthood, with
a mean age of sudden death of 41 ± 15 years. BrS is associated
with no clearly apparent structural heart diseases; however,
several clinical studies have reported mild right and left ven-
tricular structural abnormalities.25
12.5. Diagnosis
Following three types29 of ECG pattern are described (Fig. 6):
1. Type 1 BrS is diagnosed in patients with ST segment
elevation >2 mm in > one lead among the right precordial
leads V1eV3, followed by negative T wave, positioned in
the 2nd, 3rd or 4th intercostal space occurring either
spontaneously or after provocative drug test with intrave-
nous administration of Class I antiarrhythmic drugs.
2. Type 2 BrS: characterized by saddleback type ST segment
elevation of more than 2 mm a trough and a positive or
biphasic T wave.
3. Type 3 BrS: characterized by saddleback or coved type ST
segment elevation <1 mm.
Asymptomatic patients with type 1 changes do not require
drug challenge. Other ECG abnormality consists of prolonga-
tion of PR, QRS and P wave duration and presence of S wave in
lead I, II and III. There may be prolongation of QT interval in
right precordial leads due to selective prolongation of action
potential in right ventricular epicardium.22
Concealed ECGmanifestations can be unmasked by febrile
illness, sodium channel blockers and with vagotonic drugs.
Fig. 6 e Type I II III Brugada syndrome.
i n d i a n h e a r t j o u rn a l 6 6 ( 2 0 1 4 ) 4 4 3e4 5 2 449Diagnosis of Brugada syndrome is made if Type 1 ST
elevation is present with any one of following:
(i). Documented ventricular fibrillation and/or poly-
morphic ventricular tachycardia.
(ii). Inducible VT on EPS (Electrophysiology study).
(iii). Syncope.
(iv). Nocturnal agonal respiration.
(v). Family history of sudden cardiac death in young in-
dividuals less than 45 years of age.
(vi). ST elevation with T inversion in precordial leads in
family members.
Type 2 and 3 are NOT diagnostic of BrS.22
Serial ECGs from the same patient may show all three
patterns at different times, spontaneously or after adminis-
tration of specific drugs.
Diagnosis of BrS should be considered if Type 2 or 3
changes convert to type I change on administration of sodium
channel blocking drugs but conversion from type 3 to 2 on
administration is NOT consistent with diagnosis of BrS.22
12.6. Provocative tests to unmask Brugada ECG pattern
Any of the following Sodium Channel Blocker drugs can
induce Brugada changes and can be used in electrophysiology
laboratory (EP Lab) (a). Procainamide 10 mg/kg IV over 10 min,
(b). Flec-ainide 2 mg/kg IV over 10 min or 400 mg orally or (c)
Ajmaline 1 mg/kg IV over 5 min or (d) Pilsicainide 1 mg/kg IV
over 10 min31,3212.7. Differential diagnosis (ECG mimics of BrS)
A number of diseases and conditions can lead to Brugada-like
ECG abnormality(14) (i) Atypical RBBB, (ii)Left ventricular hy-
pertrophy, (iii) Benign early repolarization, (iv)Acute Pericarditis,
(v)Acutemyocardial ischemia or infarction, (vi) acute stroke,(vii)
Pulmonary embolism, (vii) Prinzmetal angina, (viii). Dissecting
aortic aneurysm,(ix) various central and autonomic nervous
system abnormalities, (x). Duchene muscular dystrophy, (xi)Thiaminedeficiency, (xii).Hyperkalemiaorhypocalcaemia, (xiii)
Arrhythmogenic right ventricular cardiomyopathy (ARVC), (xiv)
Pectus Excavatum, (xv) Hypothermia, and (xvi) Mechanical
compression of the right ventricular outflow tract (RVOT) as
occurs in mediastinal tumor or hemopericardium.12.8. Asymptomatic type I Brugada
Many subjects displaying a type 1 ECG, spontaneous or drug-
induced, are asymptomatic. In asymptomatic patients, the
following findings are considered supportive for the diagnosis
of BrS:
i. Attenuation of ST segment elevation at peak of exercise
stress test followed by its appearance during recovery
phase.
ii. Presence of first degree AV block and left axis deviation
of the QRS.
iii. Presence of atrial fibrillation.
iv. Signal averaged ECG; Late potentials.
v. Fragmented QRS.
vi. ST-T alternans, spontaneous Ventricular Premature
Beats of LBBB morphology during prolonged ECG
recording.
vii. Ventricular ERP <200 ms recorded during EPS and HV
interval >60 m s.
viii. Absence of structural heart disease including myocar-
dial ischemia.
12.9. Prognosis and risk stratification
Following characteristics identify high risk patients:22
1. Aborted Sudden Cardiac Death.
2. Spontaneous and persistent Type I ST changes increase the
risk of SCD by 8 fold.
3. Inducible VT/VF on EPS. It also has 8 fold increase in risk of
SCD.
4. Syncope.
5. Male gender: 5 fold increase in SCD.
i n d i a n h e a r t j o u r n a l 6 6 ( 2 0 1 4 ) 4 4 3e4 5 245012.10. Brugada-like ECG pattern inducing agents
Following drugs may cause Brugada-like ECG pattern.14
1. Antiarrhythmic drugs: Flecainide, Propafenone, Ajma-
line, Procainamide, Disopyramide.
2. Calcium channel blockers like Verapamil, Nifedipine,
Diltiazem.
3. Beta blockers like Propranolol, Nadolol.
4. Nitrates: isosobide dinitrate, Nitroglycerine.
5. Potassium channel openers: Nicorandil.
6. Tricyclic antidepressants: Amitryptaline, Nortriptyline,
Desipramine, Clomipramide.
7. Tetracyclic antidepressant: Maprotiline.
8. Phenothiazines: Perphenazine, Cyamemazine.
9. Selective serotonin reuptake inhibitors: Fluoxetine.
10. Misc: Cocaine, Alcohol abuse.
12.11. Role of genetic testing
Diagnostic genetic testing can be considered21 for patients
who clinicallymanifest with symptoms of BrS and for patients
who are asymptomatic but are within a family with a known
mutation. Testing should be performed first on the family
member who is symptomatic and has clinical manifestations
of BrS. Preferably; the youngest of most severely affected
family members should be tested first. The three possible
outcomes of genetic testing are: positive, negative, and variant
of unknown clinical significance (VOUS). Identification of a
mutation in the family can lead to genetic identification of at
risk family members who are clinically asymptomatic and
whomay have normal ECG. Familymemberswho test positive
for the familial mutation should receive baseline electrocar-
diogram and annual ECG screening exams. Alternatively, a
negative genetic test result for the familial mutation would
obviate the need for repeated follow up examinations. Genetic
testing can be used for prenatal diagnosis. All patients who
undergo genetic testing should receive pre-test and post-test
genetic counseling to understand the implications of
testing.27e3312.12. Catheter ablation of BrS
The underlying electrophysiological mechanism in patients
with BrS is delayed depolarization over the anterior aspect of
the RVOT epicardium. Catheter ablation over this abnormal
area results in normalization of the Brugada ECG pattern and
prevents VT/VF, both during electrophysiological studies as
well as spontaneous recurrent VT/VF episodes.34,35 Epicardial
radiofrequency ablation after pericardial access is in a state of
evaluation and no clear-cut guidelines are available at this
stage.12.13. Treatment of Brugada syndrome
Following are guidelines/recommendations from latest
consensus statement from HRS/ESC/ACC for treatment of
BrS22:12.14. Class I
1. The following lifestyle changes are recommended in all
patients with diagnosis of BrS:
a) Avoiding of drugs that may induce or aggravate ST
segment elevation in right precordial leads,
b) Avoiding of excessive alcohol intake,
c) Immediate treatment of fever with antipyretic drugs.
2. ICD implantation is recommended only in patients with a
diagnosis of BrS who:
a) Are survivors of a cardiac arrest, and/or
b) Have documented spontaneous sustained VT with or
without syncope.12.15. Class II a
1. ICD implantation can be useful in patients with a sponta-
neous diagnostic Type I ECGwho have a history of syncope
judged to be likely caused by ventricular arrhythmias.
2. Quinidine can be useful in patients with a diagnosis of BrS
and history of arrhythmic storms defined asmore than two
episodes of VT/VF in 24 h.
3. Quinidine can also be useful in patients with a diagnosis of
BrS:
a) Who qualify for an ICD but present a contraindication to
the ICD or refuse it, and/or
b) Have a history of documented supra-ventricular
arrhythmia that requires treatment.
4. Isoproterenol infusion can be useful in suppressing VT
storms in BrS patients.12.16. Class II b
1. ICD implantation may be considered in patients with a
diagnosis of BrS who develop VF during programmed
electrical stimulation (inducible patients).
2. Quinidine may be considered in asymptomatic patients
with a diagnosis of BrS with a spontaneous type 1 ECG.
3. Catheter ablation may be considered in patients with a
diagnosis of BrS and history of arrhythmic storms or
repeated appropriate ICD shocks.12.17. Class III
ICD implantation is not indicated in asymptomatic BrS pa-
tients with a drug-induced type I ECG and on the basis of a
family history of SCD alone.
12.18. Conclusion
The cause of death in BrS is VF. The episodes of syncope
(fainting) and sudden death or aborted sudden death are
caused by fast polymorphic ventricular tachycardia or VF.
These arrhythmias appearwith nowarning but fever probably
is common occurrence. While there is no exact treatment
modality that reliably and totally prevents ventricular fibril-
lation from occurring in this syndrome, treatment lies in





 Average age of first event 35 35e40
 Male predominance 75% 75%
 EKG temporal variation Yes Yes
 Vagally mediated EKG
accentuation
Yes Yes
 Ascending ST after J-point
with lower risk
Yes Yes in type II
and III
 EKG normalization with
quinidine
Yes Yes
i n d i a n h e a r t j o u rn a l 6 6 ( 2 0 1 4 ) 4 4 3e4 5 2 451termination of this lethal arrhythmia before it causes death
and is done by implantation of an implantable cardioverter-
defibrillator (ICD). Some recently performed studies had
evaluated the role of quinidine, a Class IA antiarrhythmic
drug, for decreasing VF episodes occurring in this syndrome.
Quinidine was found to decrease number of VF episodes and
correcting spontaneous ECG changes, possibly via inhibiting
Itochannels. Some drugs have been reported to induce the
type-1 ECG and/or (fatal) arrhythmias in Brugada syndrome
patients. Patients with Brugada syndrome can prevent ar-
rhythmias by avoiding these drugs, or use them only in
controlled conditions. Those with risk factors for coronary
artery disease may require a coronary angiogram before ICD
implantation. J wave syndromes viz ER and BrS do have some
similarities as shown in Table 1.Conflicts of interest
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Circ J. 2008 Jun;72:1025e1029.ObituaryDr Raj TandonA revered teacher, a
superb clinician, and the
father figure of paediat-
ric cardiology in India e
Professor Rajendra Tan-
don passed away on 26th
of February 2014, after a
brief illness. He provides
inspiration to countless
cardiologists in India
over 2 generations. His
committed contribu-tions, over a long distinguished career, have laid the founda-
tions on which the edifice of modern paediatric cardiology is
rising to greater and greater heights in India. Dr. Tandon was
Born on 21st Jan 1931 in Lucknow, and had his early medical
education at the King George Medical College (KGMC) in the
fifties. Subsequently, he was trained at Boston children's
hospital in the ‘new’ speciality of paediatric cardiology.
Despite ample opportunities to stay abroad, he chose to return
to India. He then joined the then nascent Cardiology Depart-
ment at the AIIMS in 1963. He nurtured the department and
spent almost his entire professional career there before su-
perannuating as the Chief of the Cardiothoracic Centre. He
established paediatric cardiology as an independent subspe-
cialty in India. His academic contributions in the field ofpaediatric cardiology are internationally acclaimed. His
mastery over the discipline of paediatric cardiology was
complete and his commitment to teaching was unparalleled.
He magically explored the tripod of clinical examination,
electrocardiography and chest X-ray to the delight of the
students for years with undiminished enthusiasm.
His gentleness and warmth endeared him to his pupils
who were greatly inspired by his precept and practice. He has
set the highest standards for professional conduct and aca-
demic honesty for himself which influenced people around
him. In fact, his influence on the students went beyond car-
diology, and verily touched the student's hearts and shaped
their core values which, they in turnwould pass on to the next
generation. In this sense, Prof. Tandon truly exemplifies the
statement thateA teacher influences eternity, you cannot tell
where his influence stops. He was the founder member and
patron of the paediatric cardiac society of India. He is survived
by his wife, and two sons.Compiled by
Dr. K.C. Goswami
AIIMS, New Delhi
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